JP Morgan Chase’s Compugen CGEN Stock Holding History

JP Morgan Chase’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50,000	Closed	-$414K	–	6503
2021 Q2	$414K	Hold	50,000	–	–	﹤0.01%	4817
2021 Q1	$430K	Buy	+50,000	New	+$554K	﹤0.01%	4768

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return

JP Morgan Chase's CGEN Position: Q2 2026 in Review

JP Morgan Chase sold out of Compugen (CGEN) in Q2 2026, closing a stake of 2,070 shares — an estimated $4.12K sold.

JP Morgan Chase first reported a position in CGEN in Q2 2017 and held it in 25 quarters. The position peaked at $2.22M in Q1 2021. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

JP Morgan Chase reported no remaining Compugen position as of Q2 2026 after selling out during the quarter.
JP Morgan Chase sold 2,070 Compugen shares in Q2 2026, an estimated $4.12K.
JP Morgan Chase first reported a position in Compugen in Q2 2017 and held it in 25 quarters.
JP Morgan Chase's Compugen position peaked at $2.22M in Q1 2021.
82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.